Hirschfield GM, Kowdley KV, Trivedi PJ, Eksteen B, et al. Phase II INTEGRIS-PSC trial of bexotegrast, an alphavbeta6/alphavbeta1 integrin inhibitor, in primary sclerosing cholangitis. J Hepatol 2025 Sep 26:S0168-8278(25)02498-5. doi: 10.1016/j.jhep.2025.
PMID: 41016442